Hat mitgewirkt an:
-
CAR-T-Zelltherapie mit ciltacabtagene autoleucel bei mehrfach vorbehandelten Patient*innen mit Multiplem Myelom
-
Challenges in the cultural adaptation of the German Myeloma Patient Outcome Scale (MyPOS) : : an outcome measure to support routine symptom assessment in myeloma care
-
Challenges in the cultural adaptation of the German Myeloma Patient Outcome Scale (MyPOS): an outcome measure to support routine symptom assessment in myeloma care
-
Repurposing of the ALK inhibitor crizotinib for acute leukemia and multiple myeloma cells